Octapharma

Octapharma is a global biopharmaceutical company that develops and produces medicines derived from human blood plasma. These medicines are used to treat rare, chronic, and life-threatening conditions, such as immune deficiencies, bleeding disorders, and certain neurological diseases. The company focuses on plasma-based therapies, utilizing advanced processes to ensure safety and efficacy. As a leader in the field, Octapharma emphasizes innovation, quality, and ethical practices to provide patients with vital treatments that improve their health and quality of life.